Cequr Simplicity
Payments companies reported to CMS as associated with Cequr Simplicity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cequr Simplicity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cequr Simplicity
These are the largest totals companies reported as associated with Cequr Simplicity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Levy | New York, NY | Endocrinology, Diabetes & Metabolism | $103,185.37 |
| Vinay Kapoor | Manhasset, NY | Endocrinology, Diabetes & Metabolism | $31,381.29 |
| Amit Bhargava | Modesto, CA | Endocrinology, Diabetes & Metabolism | $29,377.72 |
| Alyssa Greenleaf | Southington, CT | Medical | $22,314.47 |
| Martin Sarkar | Frederick, MD | Endocrinology, Diabetes & Metabolism | $21,872.34 |
| Philip Rabito | New York, NY | $21,520.49 | |
| Michael Valitutto | Kalamazoo, MI | Internal Medicine | $20,093.10 |
| Kalpana Reddy | Flushing, NY | Endocrinology, Diabetes & Metabolism | $18,818.02 |
| Xu He | Redlands, CA | Internal Medicine | $16,440.57 |
| Carolyn Nelson | Savannah, GA | Endocrinology, Diabetes & Metabolism | $11,456.14 |
Prescribed Cequr Simplicity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.